PharmaCielo Stock

PharmaCielo Ltd. is a global company privately held and headquartered in Canada.

About PharmaCielo Stock

PharmaCielo Ltd. is a global company privately held and headquartered in Canada. PharmaCielo Colombia Holdings S.A.S., its wholly owned operating subsidiary, is headquartered in Rionegro, Colombia. Canada was selected as the ideal country in which to headquarter our global parent based on its high standards of financial accountability and regulatory oversight. Additionally, Canada is lauded for its leadership in having established an innovative and highly regulated national medical cannabis industry.

Funding History

May 2016	$4.0M
July 2017	$6.7M
December 2017	$2.0M

Management

Director and CEO

Anthony Wile

Other Companies

Learn More

Cannabix Technologies

Cannabix Technologies has the exclusive North American license for the Cannabix Marijuana Breathalyzer.

N/AAge (years)

$0Total Funding

Learn More

Emerald Health Therapeutics

Emerald Health Therapeutics is a Health Canada Licensed Producer of medical cannabis.

Medical Cannabis Company

Steep Hill Labs opened the first commercial cannabis lab in the United States in 2007.

Discovering predictive biomarkers to eradicate all diseases.

5Age (years)

$15.0MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from PharmaCielo or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 250K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.